🟢 Sionna Therapeutics is trading 10.98% up today after its August 10 Phase 2a failure

Sionna Therapeutics is trading 10.98% up now at $5.66 amid a volatile rebound after its August 10 Phase 2a failure.

• SION-719 produced a -1.0 mmol/L placebo-adjusted sweat-chloride change (p=0.7), and the company will not advance it as an add-on to standard care.
• Shares fell 91.18% on August 10 before recovering 13.33% on August 11.